| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3343428 | Best Practice & Research Clinical Rheumatology | 2007 | 17 Pages |
Abstract
Rapid advances in understanding the immunopathogenesis of systemic lupus erythematosus (SLE) have yielded an unprecedented era of discovery of new targets with therapeutic potential. Recent clinical trials have also shed light on the optimal utility of several traditional therapies used in our SLE armamentarium.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Immunology, Allergology and Rheumatology
Authors
Jennifer K. King, Bevra H. Hahn,